← Back to catalogue

Vysis

FDA UDI

Class II (US FDA UDI)

by Abbott Molecular

Identity

Trade Name
Vysis FDA UDI
Generic Name
Human epidermal growth factor receptor 2 (HER2) protein IVD, control FDA UDI
Device Name
ProbeChek PATHVISION HER-2/neu Normal Control Slides FDA UDI
Model / Reference
02J05-010 FDA UDI
Description
ProbeChek PATHVISION HER-2/neu Normal Control Slides FDA UDI

Identifiers

Catalog Number
02J05-010 FDA UDI
Primary DI / UDI-DI
00884999001848 FDA UDI
510(k) Number
FDA Product Code
NTH FDA UDI
GMDN Term
Human epidermal growth factor receptor 2 (HER2) protein IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.4700 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Human epidermal growth factor receptor 2 (HER2) protein IVD, control

Vysis by Abbott Molecular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Human epidermal growth factor receptor 2 (HER2) protein IVD, control.

Cleared under the same submission

DEN040010 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Molecular

Sources (1)

  • FDA UDI b0a5fab5-7693-4be6-8605-7a3cd4c99223 37 fields · synced May 30, 2026